DONALD DIEFENDORF: Open Payments
NPI 1437187002 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 39 payments from 10 companies in 2025. Trend: 2023 $520 · 2024 $565 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $189 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Exact Sciences Corporation | 5 | $113 |
| Lilly USA, LLC | 5 | $95 |
| PFIZER INC. | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $85 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Philips North America LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: Ozempic, BREZTRI, MOUNJARO, Kerendia, Cologuard Collection Kit, AIRSUPRA, PREVNAR 20, CAPVAXIVE.
Industry payments across MD — which companies pay providers there.
